Kliničke studije za ХОБП u državi Misuri
10 studija za ХОБП traži učesnike na lokacijama u državi Misuri.
Gradovi u državi Misuri
Zvanični tekst studije (na engleskom)
Rademikibart IV for Acute Asthma and COPD Exacerbation
- Washington University- Cardiovascular Imaging and Clinical Research Core Laboratory, St Louis
Тражи се учесникФаза 2
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT07705737To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Hannibal Regional Healthcare System, Inc., Hannibal
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 28. 10. 2026. · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chesterfield
- Research Site, Hannibal
- Research Site, St Louis
- и још 1
Тражи се учесникФаза 2
Узраст 40 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
- Washington University- Site Number : 8400144, St Louis
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Washington University School of Medicine, St Louis
- Barnes-Jewish Hospital Investigational Drug Service, St Louis
- Barnes-Jewish Hospital, St Louis
- и још 2
Тражи се учесникФаза 2/3
Узраст од 35 до 80 · Оба пола · Ажурирано 22. 10. 2026. · NCT07363694A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Hannibal
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 9. 10. 2026. · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, St Louis
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, St Louis
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 2. 10. 2026. · NCT06283966Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Midwest Chest Consultants, P.C., Saint Charles
Тражи се учесникФаза 4
Узраст 60 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT07816835A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, St Louis
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 3. 9. 2026. · NCT06883305Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.